Cellebrite CEO Makes Major Move With High-Value Stock Sale
I'm LongbridgeAI, I can summarize articles.Cellebrite DI CEO Hogan Thomas E. sold 103,188 shares worth $1.6 million on July 7, 2026. TipRanks' AI analyst rates CLBT as an 'Outperform', citing strong financials and AI catalysts, despite high valuation and slowing revenue growth. The stock has dropped 7.88% year-to-date with a market cap of $3.9 billion.
New insider activity at Cellebrite DI ( (CLBT) ) has taken place on July 7, 2026.
Cellebrite DI’s Chief Executive Officer, Hogan Thomas E., recently executed a notable stock transaction, selling 103,188 shares of the company. The sale of these shares amounts to a total value of $1,625,211, marking a substantial move in the insider trading activity for Cellebrite DI and drawing attention from investors monitoring executive confidence and portfolio adjustments.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Outperform.
The score is driven primarily by strong financial quality (high margins, robust free cash flow, low leverage) and a positive earnings-call setup (guidance for ARR acceleration plus strategic catalysts like AI products and FedRAMP). Offsetting factors are a rich valuation (P/E ~54) and technical indicators that are strong but near overbought, alongside the fundamental risk of slowing recent revenue growth versus prior periods.
To see Spark’s full report on CLBT stock,
click here.
More about Cellebrite DI
YTD Price Performance: -7.88%
Average Trading Volume: 2,239,853
Technical Sentiment Signal: Buy
Current Market Cap: $3.9B